Current concepts in the treatment of depression in alcohol-dependent patients (Q34123886)

31 July 2017

1 reference

title

Current concepts in the treatment of depression in alcohol-dependent patients (English)

1 reference

31 July 2017

3

Quitkin FM

1 reference

31 July 2017

2

Nunes EV

1 reference

31 July 2017

McGrath PJ

1

1 reference

31 July 2017

1 December 2000

1 reference

Psychiatric Clinics of North America

31 July 2017

1 reference

31 July 2017

23

1 reference

31 July 2017

695-711, V

1 reference

31 July 2017

4

1 reference

Carbohydrate-deficient transferrin as an indicator of drinking status during a treatment outcome study

31 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970192-1

7 January 2021

Comparison of CAGE questionnaire and computer-assisted laboratory profiles in screening for covert alcoholism

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970192-1

7 January 2021

A computerized biochemical profile for detection of alcoholism

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970192-1

7 January 2021

Limitations of the Application of Fourfold Table Analysis to Hospital Data

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970192-1

7 January 2021

Alcoholism and affective disorder: clinical course of depressive symptoms

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970192-1

7 January 2021

Tricyclic antidepressants in the treatment of depression associated with alcoholism

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970192-1

7 January 2021

Fluoxetine in depressed alcoholics. A double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970192-1

7 January 2021

Major depression in a nonclinical sample. Demographic and clinical risk factors for first onset

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970192-1

7 January 2021

The safety profile of naltrexone in the treatment of alcoholism. Results from a multicenter usage study. The Naltrexone Usage Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970192-1

7 January 2021

Spontaneous and ethanol-stimulated in vitro release of beta-endorphin by the hypothalamus of AA and ANA rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970192-1

7 January 2021

Adolescent depression, alcohol and drug abuse.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970192-1

7 January 2021

Lithium treatment of depressed and nondepressed alcoholics.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970192-1

7 January 2021

Disulfiram treatment of alcoholism. A Veterans Administration cooperative study

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970192-1

7 January 2021

Network therapy for addiction: a model for office practice

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970192-1

7 January 2021

Comorbidity between DSM-IV alcohol use disorders and major depression: results of a national survey

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970192-1

7 January 2021

The relationship between DSM-IV alcohol use disorders and DSM-IV major depression: examination of the primary-secondary distinction in a general population sample

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970192-1

7 January 2021

Alcoholism and major depression in women. A twin study of the causes of comorbidity

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970192-1

7 January 2021

The self-medication hypothesis of addictive disorders: focus on heroin and cocaine dependence

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970192-1

7 January 2021

Placebo-controlled trial of fluoxetine as an adjunct to relapse prevention in alcoholics

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970192-1

7 January 2021

A double-blind, placebo-controlled trial of desipramine for primary alcohol dependence stratified on the presence or absence of major depression

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970192-1

7 January 2021

Imipramine treatment of alcoholics with primary depression: A placebo-controlled clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970192-1

7 January 2021

Comorbidity and co-transmission of alcoholism, anxiety and depression

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970192-1

7 January 2021

Prognostic effect of the variable course of alcoholism on the 10-year course of depression.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970192-1

7 January 2021

Multiple Risk Factors Predict Suicide in Alcoholism

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970192-1

7 January 2021

Fluoxetine differentially alters alcohol intake and other consummatory behaviors in problem drinkers.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970192-1

7 January 2021

Zimelidine-induced variations in alcohol intake by nondepressed heavy drinkers

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970192-1

7 January 2021

The serotonin uptake inhibitor citalopram attenuates ethanol intake

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970192-1

7 January 2021

Differential effects of viqualine on alcohol intake and other consummatory behaviors

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970192-1

7 January 2021

Imipramine treatment of alcoholism with comorbid depression

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970192-1

7 January 2021

Antabuse contracts for married alcoholics and their spouses: a method to maintain antabuse ingestion and decrease conflict about drinking

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970192-1

7 January 2021

Naltrexone and coping skills therapy for alcohol dependence. A controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970192-1

7 January 2021

Matching Alcoholism Treatments to Client Heterogeneity: Project MATCH Three-Year Drinking Outcomes

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970192-1

7 January 2021

Matching alcoholism treatments to client heterogeneity: treatment main effects and matching effects on drinking during treatment. Project MATCH Research Group

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970192-1

7 January 2021

Phobic anxiety syndrome complicated by drug dependence and addiction. A treatable form of drug abuse.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970192-1

7 January 2021

Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) Study

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970192-1

7 January 2021

Psychopathology as a predictor of treatment outcome in alcoholics.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970192-1

7 January 2021

The clinical implications of primary diagnostic groups among alcoholics

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970192-1

7 January 2021

Comparison of induced and independent major depressive disorders in 2,945 alcoholics

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970192-1

7 January 2021

The life-time rates of three major mood disorders and four major anxiety disorders in alcoholics and controls

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970192-1

7 January 2021

Effect of cigarette smoking on alcohol treatment outcome

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970192-1

7 January 2021

Naltrexone in the treatment of alcohol dependence

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970192-1

7 January 2021

Drug abuse as self-medication for depression: an empirical study

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970192-1

7 January 2021

10.1016/S0193-953X(05)70192-1

Identifiers

DOI

1 reference

31 July 2017

1 reference

PubMed ID

11147242